Research
Information as it pertains to research of peptides and the science-y side of things.
Retatrutide: What the Latest Phase 3 Data Tells Us -- and What Happens Next
For several years, retatrutide has carried one of the biggest reputations in obesity research. Now we finally have enough Phase 3 evidence to start separating the reputation from the data. And the data is substantial. Retatrutide, formerly known as LY3437943, is Eli Lilly's investigational once-weekly "triple agonist". The molecule activates three hormone receptors:- GLP-1- GIP- […]
What We Mean by Levels of Evidence
When we talk about peptide research, one phrase is going to appear frequently on this site: "What is the evidence?" That sounds like a simple question, but it isn't. Evidence exists on a spectrum. A biological mechanism observed in a laboratory, an experiment in mice, a randomized human trial, and thousands of people reporting similar […]


